Atul Malhotra (@Atul_Monash) header
Atul Malhotra (@Atul_Monash) profile picture
Melbourne, Australia
Joined May 2018
Photo by Atul Malhotra (@Atul_Monash)Photo by Atul Malhotra (@Atul_Monash)Photo by Atul Malhotra (@Atul_Monash)Photo by Atul Malhotra (@Atul_Monash)Photo by Atul Malhotra (@Atul_Monash)Photo by Atul Malhotra (@Atul_Monash)Photo by Atul Malhotra (@Atul_Monash)Photo by Atul Malhotra (@Atul_Monash)Photo by Atul Malhotra (@Atul_Monash)Photo by Atul Malhotra (@Atul_Monash)
Early Neurodevelopment of Extremely Preterm Infants Administered Autologous Cord Blood Cell Therapy Secondary Analysis of MRI brain and early neurodevelopment of CORD-SaFe study now out in @JAMANetworkOpen jamanetwork.com/journals/jam… @LindsayDZhou @EBNEO @ESPR_ESN @nicupodcast
4
11
34
3,744
Our Cochrane review on vitamin D supplementation in preterm and LBW infants involving 34 studies (5012 infants) shows the vit D supplementation ( dose 200- 800 IU) is safe and reduces vitamin D deficiency. However, the dose >800 IU may lead to excess level cochranelibrary.com/web/coch…
1
2
132
Join us in Prato in May 2027 Registrations now open: monash.edu/medicine/news/eve…
2
2
318
Regenerative Cell and Cell-Free Therapies for Necrotizing Enterocolitis: Progress Toward Clinical Translation thieme-connect.de/products/e… – at Melbourne, Victoria
4
333
Progress in cell therapies for neonatal conditions: Proceedings of the Third Neonatal Cell Therapies Symposium (2025) nature.com/articles/s41390-0… @DrAbdulRazak_MD @Neo_CellTherapy
5
16
552
Atul Malhotra retweeted
Announcing the EBNEO Impact Article of the Year for 2025: Expectant Management vs Medication for Patent Ductus Arteriosus in Preterm Infants The PDA Randomized Clinical Trial by Laughon et al for the NICHD NRN jamanetwork.com/journals/jam… #EBNEO #IAOTY2025 #neoEBM
2
3
1
14
1,221
What an amazing start to the day! So far, we've sat down with Dr. Elena Itriago of @Incubadorapod, discussed Neonatal Pulmonary Hypertension with @neocardiolab (@CardioNeo), and cell therapy with @Atul_Monash. Much more to come! Stay tuned. @PASMeeting
3
1
11
763
Atul Malhotra retweeted
The @EBNeo 2025 Impact Article of the Year race is down to the final two! After a high-stakes first round, these 2 RCTs have emerged as the frontrunners: Faix et al. Laughon et al. Vote now to crown the winner! 🗳️ ⏳ Open for 5 days only! buff.ly/XvU87C4
2
4
1
7
1,734
Attending @PASMeeting in Boston later this month? Come and learn about neonatal cell therapies research with our international panels of experts pas-meeting.org/2026-meeting…
4
12
745
Atul Malhotra retweeted
Which research shaped neonatology in 2025? 🚀 The EBNEO Impact Article of the Year finalists are live! Help us narrow 8 candidates down to the top 2. Voting is open for 7 days. Make your choice on our website: ebneo.org/impact #IAOTY #EBNeoPolls
6
1
10
1,201
New study from our group led by Tegan White combines human and animal data to show that fetal growth restriction impairs postnatal brain development. Brain Journal academic.oup.com/brain/advan…
2
1
8
387
Pleased to share, we have crossed 50% recruitment for the Allo trial Safety and feasibility of allogeneic cord blood-derived cell therapy in preterm infants with severe brain injury pubmed.ncbi.nlm.nih.gov/4053…
3
12
480
More data on growth issues following NEC in preterm infants in Pediatric Research Paper: nature.com/articles/s41390-0… Commentary: nature.com/articles/s41390-0…
2
191